Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
Aclarion, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $3.37
-37% since the alert
$5.37 → $3.37
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS